Skip to main content
Elsevier
View Cart
openUserAccount

Books in Hepatology

BooksJournals
61-70 of 70 results in All results

Hepatobiliary Manifestations of Diseases Involving Other Organ Systems , An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 15-1
  • December 22, 2010
  • Ke-Qin Hu
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 0 5 2 6 - 9
In this issue, Dr. Hu provides comprehensive coverage of disease states that cause abnormal liver function. The authors focus articles on the presentation and diagnosis, with treatment of the liver concurrent to treatment of the disease. Disease states covered include pulmonary, cardiovascular, renal, endocrine, hematologic/oncologic, gastroenterologic, and rheumatologic, and dermatologic.

Diagnostic Challenges in Liver Pathology, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 14-4
  • November 30, 2010
  • Jay H. Lefkowitch
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 2 5 3 3 - 9
Dr. Lefkowitch is one the most well known experts on liver pathology and has updated the topic since it last published over 5 years ago. Important topics updated include benign liver tumor, vascular disorders of the liver, autoimmune hepatitis, and non-alcoholic fatty liver disease. Special emphasis is given to articles devoted to immunochemistry in liver tumors, hepatic granulomas, and diagnostic pitfalls in liver transplantation.

Chronic Hepatitis B: An Update, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 14-3
  • August 11, 2010
  • Naoky C.S. Tsai
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 2 5 3 2 - 2
A recent Institute of Medicine report has concluded that "there is a lack of knowledge and awareness about chronic viral hepatitis on the part of health-care and social-service providers, as well as among at-risk populations, members of the public, and policy-makers. Due to the insufficient understanding about the extent and seriousness of this public-health problem, inadequate public resources are being allocated to prevention, control, and surveillance programs". It is with these concerns in mind that Dr. Tsai assembled a group of experts in this field to present their expertise in such a level, where the practicing clinicians who deal with this disease in their daily practice can understand thereby implement this knowledge into their own practice. Dr. Brian McMahon discusses the natural history of chronic hepatitis B with his vast knowledge and experience working with the high endemic population of Inuit in Alaska; Drs. Marc Ghany and Ed provide a very easy-to-understand description of HBV virology; Dr. Kyon-Mi Chang contributes an article on HBV immunology, which is the least understood area of this disease but has the most potential to improve our knowledge in the management of chronic hepatitis B; Dr. Anna Lok provides an authoritative review on the current issues and controversies of treatment of chronic hepatitis B; Dr. Stephen Locarnini, who has extensive experience in anti-viral resistance and its management, presents important issues in the usage of currently available anti-viral oral agents; Dr. Myron Tong discusses the current understanding of HBV carcinogenesis and updates HCC surveillance and treatment-- the most dreadful outcome of this disease; Dr. Paul Martin discusses management of end- stage chronic hepatitis B -anti-viral therapy, montherapy vs combo.therapy, choice of agent, when to start therapy and post-transplant patients including duration of HBIG therapy, HBcAb(+)only recipient) and Occult HBV infection; Dr. Tram Tran discuss the treatment in reproductive women, during pregnancy, and prevention of vertical transmission in third trimester with antiviral agents-- an area with significant lack of good clinical evidence; Dr. Steve Han discuss management of patients with acute hepatitis B, co-infection with HDV/HCV/HIV, pre-immuno-suppressive therapy, and management of renal and heart transplant patients with HBV infection; Dr. Mei Huei Chang discusses Taiwanese success in implementing universal vaccination leading to a remarkable reduction in both prevalence of chronic hepatitis B and incidence of hepatocellular carcinoma; and finally Drs. Michelle Lai and Yun Fan Liaw provide a rundown of what we have accomplished and the hope for the future in our fight to control this disease.

Endoscopy and Liver Disease, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 14-2
  • June 29, 2010
  • Andres Cardenas + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 1 9 1 4 - 7
Gastrointestinal endoscopy plays an essential role in the management of patients with liver disease. This issue reviews the standard of care in the endoscopic management of portal hypertension and biliary disease before and after liver transplantation. A thorough knowledge of the available endoscopic diagnostic and therapeutic methods is essential for the practicing hepatologist. Emphasis is placed on recent advances in imaging techniques such as the application of capsule endoscopy and endoscopic ultrasound in the evaluation of portal hypertension and recent advances in cholangioscopy and biliary tissue sampling. Additionally new information regarding the endoscopic management of esophageal and gastric varices is reviewed. Finally, the current role of ERCP in the diagnosis and staging of cholangiocarcinoma before liver transplantation and the endoscopic management of biliary complications after liver transplantation is discussed.

Health Care-Associated Transmission of Hepatitis B and C Viruses, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 14-1
  • February 25, 2010
  • Bandar Al Knawy
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 1 9 1 5 - 4
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 0 0 4 0 - 0
This issue offers the latest information regarding the transmission of hepatitis viruses in various healthcare settings. It delves with a very timely and interesting patient safety subject that specifically targets healthcare professionals, gastroenterologists, hepatologists, oncologists, dentists and all healthcare workers to adopt and share a variety of best practices to prevent this adverse event. Well known faculty in liver disease, infection control as well as a medical practice in a legal setting have been assembled to produce a comprehensive and concise edition that highlights the latest information regarding hepatitis B and C transmission in healthcare. It aims to provide an overview on the molecular epidemiology, the outbreak reports, the transmission in hemodialysis, endoscopy, dental, oncology, management, legal aspects and the infection prevention measures to reduce the risk of needless exposure of patients to these blood borne pathogens.

Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases

  • 1st Edition
  • December 15, 2009
  • Mamun-Al-Mahtab
  • English
  • eBook
    9 7 8 - 8 1 - 3 1 2 - 3 1 5 7 - 9
The spectrum and etiology of liver diseases vary widely between East and West and hence the focus and experience of hepatologists also remain varied at two corners of the globe. Hepatology being perhaps one of the most flourishing and evolving discipline of medical sciences, a book with recent information written by experts from all over the world was much needed. The present book fulfills this need. The book will serve as a useful reference manual to consultants, postgraduate students, and residents of Hepatology, Gastroenterology, Internal Medicine, Pathology, Virology, and Preventive Medicine as well as undergraduate clinical medical students.

Non-Alcoholic Steatohepatitis, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 13-4
  • October 30, 2009
  • Stephen A. Harrison
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 1 2 3 7 - 7
This issue presents the views of internationally renowned experts on current findings concerning the epidemiology, natural history, diagnosis, pathogenesis, and treatment of non-alcoholic steatohepatitis. Articles are included on bariatric surgery, liver transplantation, cytokines and apoptosis, as well as insulin resistence and lipotoxicity, to name a few. The Guest Editor himself ends the issue with an article giving his overall perspective on the current clinical management of NASH and future directions.

Novel Therapies in Hepatitis C Virus, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 13-3
  • August 19, 2009
  • Paul J. Pockros
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 1 2 3 6 - 0
The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few.

Key Consultations in Hepatology, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 13-2
  • June 17, 2009
  • Paul Martin
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 0 4 9 6 - 9
Often the hepatologist sees patients in consultation, and this issue focuses on how to deal with diagnosing, treating, and managing patients in the hospital on a consultation basis. The Guest Editor has assembled top experts to present articles on the asymptomatic outpatient with abnormal LFTs, surgery in the patient with liver disease, issues in long-term care of liver transplant recipients, management of autoimmune cholestatic liver disease, and current status of hepatitis vaccination and prophylaxis, to name a few.

Coagulation and Hemostasis in Liver Disease: Controversies and Advances, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 13-1
  • February 9, 2009
  • Arun J. Sanyal + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 0 4 9 5 - 2
In this issue, the Guest Editors have focused on recent advances in liver disease related to disturbances in hemostasis and coagulation. The work emphasizes the multifaceted aspects of coagulation disorders in liver disease from hypo-coagulable to hyper-coagulable states and the limitations of conventional tests such as the INR to shed light on relative bleeding risk or on underlying pathophysiology in a given patient. Articles are written by leaders in the field from multiple disciplines and from around the world. In each article, the state of the art is discussed along with its limitations. The issue sheds light on recent advances, explores areas of controversy, and thus, addresses the need of combined clinical and laboratory investigation.